Nūhou maikaʻi:

Ua hoʻopau ʻo Bioantibody i kāna pōʻai kālā mua ma kahi o 100 miliona yuan.Ua alakaʻi pū ʻia kēia kālā e Fang Fund, New Industry Investment, Guoqian Venture Investment, bondshine capital a me Phoeixe Tree Investment.
E hoʻohana ʻia ke kālā no ka wikiwiki ʻana i ka hoʻolālā hohonu o Bioantibody i ka lawe ʻana mai i nā papa hana automated a hoʻohui ʻia a me ka hana pilikino OEM/ODM platforms no nā antibodies, #IVD Products, a me nā lawelawe ʻenehana pili.

Kūleʻa ʻo Bioantibody i ka R&D, ka hana ʻana a me ke kūʻai aku ʻana i nā kumu kumu kumu no ka IVD a me nā biopharmaceuticals.Ma muli o ka ʻenehana fusion cell hybridoma kiʻekiʻe i manaʻo ʻia a me ke kākoʻo o ka cell stable growth factor a me ka paepae screening high-throughput, ua hoʻomohala ka ʻoihana i kekahi mau huahana me ka hana i hoʻohālikelike ʻia a ʻoi aku paha ma mua o ka papa mua o ka honua IVD raw material. , a ua hoʻokō maikaʻi i ka ʻoihana kalepa.Ua ʻike nui ʻia a kūʻai pinepine ʻia e nā mea kūʻai aku o nā ʻoihana inoa inoa IVD kaulana i Kina.

ʻO Bioantibody mai kona hoʻomaka ʻana e kūpaʻa mau i kona manaʻo mua, e ʻimi ana i ka hana hou a me nā lawelawe mālama olakino.

Hoʻomaikaʻi!!